CT26-mock or CT26-ULBP2 tumor cells were subcutaneously transplanted into syngeneic BALB/c mice, which were then treated with either an isotype control antibody or anti-CTLA-4 antibody. The gene discussed is CTLA4; the disease is neoplasm.